Statistical Hypotheses Sample Clauses

Statistical Hypotheses. No inferences are to be made on the primary effectiveness endpoint; therefore, no hypotheses are formulated.
Statistical Hypotheses. No hypothesis testing of the primary effectiveness endpoint is planned.
Statistical Hypotheses. The null and alternative hypotheses are formulated in terms of the predefined margin of 0.05 for noninferiority: H0: µ(T) – µ(C) ≥ 0.05 Ha: µ(T) – µ(C) < 0.05 where µ(T) and µ(C) denote the mean distance VA for PRECISION1 and Biotrue, respectively, on the logMAR scale.
Statistical Hypotheses. The null and alternative hypotheses are formulated in terms of the predefined margin of 0.10 (10%) for noninferiority. H0: P(T) – P(C) ≤ -0.10 Ha: P(T) – P(C) > -0.10 where P(T) and P(C) denote the proportion of subjects attaining at least 20/20 in CLCDVA at Week 1 Follow-up in each eye (OD and OS) for and Biofinity contact lenses, respectively.
Statistical Hypotheses. The null and alternative hypotheses are formulated in terms of the predefined margin of 0.10 (in logMAR scale) for noninferiority: H0: μ(T) − μ(C) ≥ 0.10 Ha: μ(T) − μ(C) < 0.10 where μ(T) and μ(C) denote the Week 1 Follow-up mean CLCDVA for contact lenses, respectively, on the logMAR scale. and Biofinity
Statistical Hypotheses. The null and alternative hypotheses are formulated in terms of the predefined margin of 1.0 for noninferiority: H0: μ(DACP D) - μ(DACP) ≤ -1.0 Ha: μ(DACP D) - μ(DACP) > -1.0 where μ(DACP D) and μ(DACP) denote the mean overall vision rating for DACP Digital and DACP, respectively.
Statistical Hypotheses. No hypothesis testing on the other safety endpoints is planned.
Statistical Hypotheses. ‌ No hypotheses will be formally tested in this study.
Statistical Hypotheses. 30 6.4.1.2 Analysis Methods 30 6.6 Handling of Missing Data 32 6.8 Safety Analysis 32 7 ADVERSE EVENTS AND DEVICE DEFICIENCIES 33 7.1 General Information 36 7.2 Monitoring for Adverse Events 39 7.3 Procedures for Recording and Reporting 39
Statistical Hypotheses. The null and alternative hypotheses for the first, fourth and fifth secondary analysis are: H0: µTFNT00VA ≥ µ839MPVA HA: µ TFNT00VA < µ839MPVA where µ TFNT00VA, µ839MPVA, refer to the mean binocular high contrast UCIVA, UCNVA or UCDVA for the test and control lenses, respectively. The null and alternative hypotheses for the second and third secondary analysis are: H0: µ TFNT00VA - µ839MPVA ≥ ∆ HA: µ TFNT00VA - µ839MPVA < ∆ where, ∆ refers to the non-inferiority margin, set at 0.1 logMAR, and µTFNT00VA, µ839MPVA, refer to the mean binocular high contrast UCDVA or UCNVA for the test and control lenses, respectively.